Fusion Capital’s Pfizer PFE Stock Holding History

Fusion Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$200K	Buy	+7,026	New	+$187K	0.04%	105

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Fusion Capital's PFE Position: Q3 2026 in Review

Fusion Capital opened a new position in Pfizer (PFE) in Q3 2026: 7,026 shares worth $200K. The stake represents 0.04% of the portfolio and ranks #105 among its holdings.

1,122 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Fusion Capital held 7,026 shares of Pfizer worth $200K as of Q3 2026.
Pfizer was a new Fusion Capital position in Q3 2026.
Pfizer made up 0.04% of Fusion Capital's portfolio in Q3 2026, its #105 holding.
1,122 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Fusion Capital's 13F filing for Q3 2026, filed 28 Oct 2026.